FDA Inspection 1202371 — Seres Therapeutics Inc
The FDA completed an inspection of Seres Therapeutics Inc on Dec 14, 2022 in Cambridge, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 14, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Cambridge, MA (United States)